Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
Black-Maier E, Lewis RK, Rehorn M, Loungani R, Friedman DJ, Frazier-Mills C, Jackson KP, Atwater BD, Milano CA, Schroder JN, Pokorney SD, Piccini JP.
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1509-1518. doi: 10.1111/jce.14487. Epub 2020 Apr 29.
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely B, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Zhang Y, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM.
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):582-90. doi: 10.1161/CIRCOUTCOMES.113.000299. Epub 2013 Sep 3.
Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve ) implantation.
Plant A, Stewart F, Hooks D.
J Cardiovasc Electrophysiol. 2024 May;35(5):1050-1054. doi: 10.1111/jce.16249. Epub 2024 Mar 19.
[Device-device interaction].
Johnson V, Hamm CW, Schmitt J.
Herzschrittmacherther Elektrophysiol. 2019 Jun;30(2):183-190. doi: 10.1007/s00399-019-0617-z. Epub 2019 Apr 15.
The story of a lead.
Nisam S, Reddy S.
Europace. 2015 May;17(5):677-88. doi: 10.1093/europace/euu391. Epub 2015 Mar 8.
Ventricular tachyarrhythmia induction by strong cardiac shocks: can understanding underlying mechanisms lead to improved prevention of defibrillator failure?
Nattel S.
Heart Rhythm. 2006 May;3(5):596-7. doi: 10.1016/j.hrthm.2006.03.024. Epub 2006 Mar 28.
Permanent Left Bundle Branch Area DF-4 Defibrillator Lead Implantation-Feasibility, Procedural Caveats, Safety, and Follow-Up.
Ghosh A, Sriram CS, Manu N, Sankaradas MA, Upadhyay GM, Pandurangi UM.
J Cardiovasc Electrophysiol. 2025 Mar;36(3):650-662. doi: 10.1111/jce.16585. Epub 2025 Jan 24.
Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy).
Plesinger F, Jurak P, Halamek J, Nejedly P, Leinveber P, Viscor I, Vondra V, McNitt S, Polonsky B, Moss AJ, Zareba W, Couderc JP.
Circ Arrhythm Electrophysiol. 2018 May;11(5):e005719. doi: 10.1161/CIRCEP.117.005719. Epub 2018 Apr 26.
